Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Laurens F. Tops"'
Autor:
Julius C. Heemelaar, Jeroen Janson, Jerry Braun, Frank M. Speetjens, Michiel A. J. van de Sande, Juan D. V. Hugo, Daniela Q. C. M. Barge-Schaapveld, Saskia L. M. A. Beeres, Laurens F. Tops, Hans Gelderblom, M. Louisa Antoni
Publikováno v:
Cardio-Oncology, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Neo(adjuvant) systemic treatment regimens containing anthracyclines such as doxorubicin cause a significant risk of heart failure. These regimens are one of the corner stones of osteosarcoma treatment, and therefore several guidelines are in
Externí odkaz:
https://doaj.org/article/5f7e209b055645dbbcbf6947d9e15655
Autor:
Michelle Feijen, Anastasia D. Egorova, Laurens F. Tops, Meindert Palmen, J. Wouter Jukema, Martin J. Schalij, Saskia L. M. A. Beeres
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 2, p 51 (2024)
Background: Survival and quality-of-life of left ventricular assist device (LVAD) recipients improved significantly because of growing experience and technological advances. However, LVAD-related complication rates, including recurrent episodes of co
Externí odkaz:
https://doaj.org/article/929d9d0855e742b6987e615b00eff0ea
Autor:
Anastasia D. Egorova, Marieke Nederend, Laurens F. Tops, Hubert W. Vliegen, Monique R.M. Jongbloed, Philippine Kiès
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 2007-2012 (2022)
Abstract In congenitally corrected transposition of the great arteries, the morphological right ventricle supports the systemic circulation. This chronic exposure to pressure overload ultimately leads to systemic right ventricular (sRV) dysfunction a
Externí odkaz:
https://doaj.org/article/202fa3d15fca4d448edea07800a84e43
Autor:
Binyamin Ben Avraham, Marisa Generosa Crespo‐Leiro, Gerasimos Filippatos, Israel Gotsman, Petar Seferovic, Tal Hasin, Luciano Potena, Davor Milicic, Andrew J.S. Coats, Giuseppe Rosano, Frank Ruschitzka, Marco Metra, Stefan Anker, Johann Altenberger, Stamatis Adamopoulos, Yaron D. Barac, Ovidiu Chioncel, Nicolaas De Jonge, Jeremy Elliston, Maria Frigeiro, Eva Goncalvesova, Avishay Grupper, Righab Hamdan, Yoav Hammer, Loreena Hill, Osnat Itzhaki Ben Zadok, Miriam Abuhazira, Jacob Lavee, Wilfried Mullens, Sanemn Nalbantgil, Massimo F. Piepoli, Piotr Ponikowski, Arsen Ristic, Arjang Ruhparwar, Aviv Shaul, Laurens F. Tops, Steven Tsui, Stephan Winnik, Tiny Jaarsma, Finn Gustafsson, Tuvia Ben Gal
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4394-4408 (2021)
Abstract The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD‐supported patients on the device and the s
Externí odkaz:
https://doaj.org/article/0041ea582f7e4623bebd0cceeb836623
Autor:
Davor Milicic, Binyamin Ben Avraham, Ovidiu Chioncel, Yaron D. Barac, Eva Goncalvesova, Avishai Grupper, Johann Altenberger, Maria Frigeiro, Arsen Ristic, Nicolaas De Jonge, Steven Tsui, Jacob Lavee, Giuseppe Rosano, Marisa Generosa Crespo‐Leiro, Andrew J.S. Coats, Petar Seferovic, Frank Ruschitzka, Marco Metra, Stefan Anker, Gerasimos Filippatos, Stamatis Adamopoulos, Miriam Abuhazira, Jeremy Elliston, Israel Gotsman, Righab Hamdan, Yoav Hammer, Tal Hasin, Lorrena Hill, Osnat Itzhaki Ben Zadok, Wilfried Mullens, Sanemn Nalbantgil, Massimo Francesco Piepoli, Piotr Ponikowski, Luciano Potena, Arjang Ruhparwar, Aviv Shaul, Laurens F. Tops, Stephan Winnik, Tiny Jaarsma, Finn Gustafsson, Tuvia Ben Gal
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4409-4424 (2021)
Abstract The improvement in left ventricular assist device (LVAD) technology and scarcity of donor hearts have increased dramatically the population of the LVAD‐supported patients and the probability of those patients to present to the emergency de
Externí odkaz:
https://doaj.org/article/d76c98eb5aa147f0b4311c6d0303362b
Autor:
Finn Gustafsson, Binyamin Ben Avraham, Ovidiu Chioncel, Tal Hasin, Avishai Grupper, Aviv Shaul, Sanemn Nalbantgil, Yoav Hammer, Wilfried Mullens, Laurens F. Tops, Jeremy Elliston, Steven Tsui, Davor Milicic, Johann Altenberger, Miriam Abuhazira, Stephan Winnik, Jacob Lavee, Massimo Francesco Piepoli, Lorrena Hill, Righab Hamdan, Arjang Ruhparwar, Stefan Anker, Marisa Generosa Crespo‐Leiro, Andrew J.S. Coats, Gerasimos Filippatos, Marco Metra, Giuseppe Rosano, Petar Seferovic, Frank Ruschitzka, Stamatis Adamopoulos, Yaron Barac, Nicolaas De Jonge, Maria Frigerio, Eva Goncalvesova, Israel Gotsman, Osnat Itzhaki Ben Zadok, Piotr Ponikowski, Luciano Potena, Arsen Ristic, Tiny Jaarsma, Tuvia Ben Gal
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4425-4443 (2021)
Abstract The growing population of left ventricular assist device (LVAD)‐supported patients increases the probability of an LVAD‐ supported patient hospitalized in the internal or surgical wards with certain expected device related, and patient
Externí odkaz:
https://doaj.org/article/eb49e5a0bdc14216a13af8bc525e6812
Autor:
Kirsten A. Kortekaas, Paul L. den Exter, Saskia L. M. A. Beeres, Meindert Palmen, J. Wouter Jukema, Menno V. Huisman, Laurens F. Tops
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Left ventricular assist device (LVAD) implantation as destination therapy (DT) is a valuable treatment option in patients with end-stage heart failure ineligible for heart transplant. However, this therapy can be complicated by life-threatening pump
Externí odkaz:
https://doaj.org/article/074b2954ce28453baa89e4b0b15cf06d
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Aims: Major adverse event (MAE) rates during left ventricular assist device (LVAD) therapy in advanced heart failure (HF) patients are high, and impair quality of life and survival. Prediction and risk stratification of MAEs in order to improve patie
Externí odkaz:
https://doaj.org/article/c51fe0b5d9ba4a34a3da26e885cd3e5c
Autor:
Finn Gustafsson, Kevin Damman, Sanem Nalbantgil, Linda W. Van Laake, Laurens F. Tops, Thomas Thum, Stamatis Adamopoulos, Michael Bonios, Andrew JS Coats, Maria G. Crespo‐Leiro, Mandeep R. Mehra, Gerasimos Filippatos, Loreena Hill, Marco Metra, Ewa Jankowska, Nicolaas de Jonge, David Kaye, Marco Masetti, John Parissis, Davor Milicic, Petar Seferovic, Giuseppe Rosano, Tuvia Ben Gal
Publikováno v:
European Journal of Heart Failure, 25(4), 457-468. Wiley
Gustafsson, F, Damman, K, Nalbantgil, S, Van Laake, L W, Tops, L F, Thum, T, Adamopoulos, S, Bonios, M, Coats, A JS, Crespo-Leiro, M G, Mehra, M R, Filippatos, G, Hill, L, Metra, M, Jankowska, E, de Jonge, N, Kaye, D, Masetti, M, Parissis, J, Milicic, D, Seferovic, P, Rosano, G & Ben Gal, T 2023, ' Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology ', European Journal of Heart Failure . https://doi.org/10.1002/ejhf.2814
Gustafsson, F, Damman, K, Nalbantgil, S, Van Laake, L W, Tops, L F, Thum, T, Adamopoulos, S, Bonios, M, Coats, A JS, Crespo-Leiro, M G, Mehra, M R, Filippatos, G, Hill, L, Metra, M, Jankowska, E, de Jonge, N, Kaye, D, Masetti, M, Parissis, J, Milicic, D, Seferovic, P, Rosano, G & Ben Gal, T 2023, ' Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology ', European Journal of Heart Failure . https://doi.org/10.1002/ejhf.2814
This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support use of inotropes in the setting of acute decompensated heart failure with evidence of organ malperfusi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aca442c0aab97f105dabcc934e03212
https://research.rug.nl/en/publications/c62655c4-f859-4efc-a5a3-8ced5a535506
https://research.rug.nl/en/publications/c62655c4-f859-4efc-a5a3-8ced5a535506
Autor:
Charles Fauvel, Guillaume Bonnet, Wilfried Mullens, Clara Ines Saldarriaga Giraldo, Anja Zupan Mežnar, Anders Barasa, Mariya Tokmakova, Anastasia Shchendrygina, Francisco Moscoso Costa, Massimo Mapelli, Filip Zemrak, Laurens F. Tops, Nina Jakus, Arian Sultan, Fadel Bahouth, Chahr‐eddine Hadjseyd, Muriel Salvat, Matteo Anselmino, Daniel Messroghli, Vanessa Weberndörfer, Ilya Giverts, Thomas Bochaton, Pierre Yves Courand, Emmanuelle Berthelot, Damien Legallois, Florence Beauvais, Fabrice Bauer, Nicolas Lamblin, Thibaud Damy, Nicolas Girerd, Laurent Sebbag, Théo Pezel, Alain Cohen‐Solal, Giuseppe Rosano, François Roubille, Nathan Mewton
Publikováno v:
European journal of heart failure, 25(2), 213-222. Wiley
European Journal of Heart Failure. WILEY
European Journal of Heart Failure
European Journal of Heart Failure. WILEY
European Journal of Heart Failure
Aims In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent international guidelines recommend initiating four major therapeutic classes rather than sequential initiation. It remains unclear how this change in guidel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2264c9167900b1bdb122c976d3b4b838
https://hdl.handle.net/1887/3567836
https://hdl.handle.net/1887/3567836